MVD Antikörper (N-Term)
Kurzübersicht für MVD Antikörper (N-Term) (ABIN453202)
Target
Alle MVD Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- This antibody reacts to MVD.
-
Aufreinigung
- Saturated Ammonium Sulfate (SAS) precipitation
-
Immunogen
- KLH conjugated synthetic peptide selected from the N-terminal region of human MVD
-
-
-
-
Applikationshinweise
-
ELISA: 1/1,000. Western blotting: 1/50 - 1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MVD (Mevalonate (Diphospho) Decarboxylase (MVD))
-
Andere Bezeichnung
- MVD
-
Hintergrund
- The enzyme mevalonate pyrophosphate decarboxylase catalyzes the conversion of mevalonate pyrophosphate into isopentenyl pyrophosphate in one of the early steps in cholesterol biosynthesis. It decarboxylates and dehydrates its substrate while hydrolyzing ATP.Synonyms: Diphosphomevalonate decarboxylase, MDDase, MPD, Mevalonate (diphospho)decarboxylase, Mevalonate pyrophosphate decarboxylase
-
Gen-ID
- 4597
-
NCBI Accession
- NP_002452
-
UniProt
- P53602
Target
-